A possible CD1a Langerhans cell-mast cell interaction in chronic hyperplastic candidosis

Journal of Oral Pathology and Medicine

Volumn 36, Issue 6, 2007, Pages 329-336

  Ali, Ahmed ^a,b   Rautemaa, Riina ^c,h   Hietanen, Jarkko ^a,c   Beklen, Arzu ^a,d   Konttinen, Yrjö ^c,e,f,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d BOGAZICI UNIVERSITY   (Turkey)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f COXA Hospital for Joint Replacement ^*  (Finland)

^g BIOMEDICUM HELSINKI   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Candida albicans; Langerhans cell; Leukoplakia; Mast cell; Receptor activator of nuclear factor kappa B ligand

Indexed keywords

AVIDIN; BIOTIN; MONOCLONAL ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PEPSIN A; PEROXIDASE; T6 ANTIGEN;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANDIDIASIS; CELL ACTIVATION; CELL INTERACTION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMINA PROPRIA; LANGERHANS CELL; LEUKOPLAKIA; MALE; MAST CELL; MONONUCLEAR CELL; MOUTH MUCOSA; PRIORITY JOURNAL; THRUSH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; HYPERPLASIA; LANGERHANS CELLS; MALE; MAST CELLS; MIDDLE AGED; MOUTH MUCOSA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 34249988787     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00527.x     Document Type: Article

References (27)

1. Appleton SS. Candidiasis: pathogenesis, clinical characteristics, and treatment. J Calif Dent Assoc 2000 28 : 942 8.
2. Rossie K, Guggenheimer J. Oral candidiasis: clinical manifestations, diagnosis, and treatment. Pract Periodontics Aesthet Dent 1997 9 : 635 41 quiz 642.
3. Odds FC. Pathogenesis of candida infections. J Am Acad Dermatol 1994 31 : S2 5.
4. Weig M, Gross U, Muhlschlegel F. Clinical aspects and pathogenesis of candida infection. Trends Microbiol 1998 6 : 468 70.
5. Farah CS, Ashman RB, Challacombe SJ. Oral candidosis. Clin Dermatol 2000 18 : 553 62.
6. Filler SG, Swerdloff JN, Hobbs C, Luckett PM. Penetration and damage of endothelial cells by Candida albicans. Infect Immun 1995 63 : 976 83.
7. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992 11 : 287 91.
8. Cawson RA, Lehner T. Chronic hyperplastic candidiasis - candidal leukoplakia. Br J Dermatol 1968 80 : 9 16.
9. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 2004 19 : 293 6.
10. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol 2001 39 : 4066 75.
11. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
12. Silberberg-Sinakin I, Thorbecke J. Contact hypersensitivity and Langerhans cells. J Invest Dermatol 1980 75 : 61 7.
13. Daniels TE. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 1984 82 : 21 4.
14. Daniels TE, Schwartz O, Larsen V, Dabelsteen E, Pindborg J. Langerhans cells in candidal leukoplakia. J Oral Pathol 1985 14 : 733 9.
15. Newman SL, Holly A. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun 2001 69 : 6813 22.
16. Ali A, Lax A, Liljeström M et al. Mast cells in atherosclerosis as a source of the cytokine RANKL. Clin Chem Lab Med 2006 44 : 672 4.
17. Scimone ML, Lutzky VP, Zittermann SI et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005 114 : 375 85.
18. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995 6 : 147 60.
19. Saglie FR, Pertuiset JH, Smith CT et al. The presence of bacteria in the oral epithelium in periodontal disease. III. Correlation with Langerhans cells. J Periodontol 1987 58 : 417 22.
20. Seguier S, Godeau G, Brousse N. Immunohistological and morphometric analysis of intra-epithelial lymphocytes and Langerhans cells in healthy and diseased human gingival tissues. Arch Oral Biol 2000 45 : 441 52.
21. Gemmell E, Carter CL, Hart DN, Drysdale KE, Seymour GJ. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol 2002 17 : 388 93.
22. Jotwani R, Cutler CW. Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res 2003 82 : 736 41.
23. Hofbauer LC, Shui C, Riggs BL et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001 280 : 334 9.
24. Burgess TL, Qian Y, Kaufman S et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999 145 : 527 38.
25. Matsuzaki K, Udagawa N, Takahashi N et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998 246 : 199 204.
26. Josien R, Wong BR, Li HL, Steinman RM, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999 162 : 2562 8.
27. Anderson DM, Maraskovsky E, Billingsley WL et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997 390 : 175 9.